Name | Value |
---|---|
Revenues | 0.0K |
Cost of Revenue | 1,074.0K |
Gross Profit | -1,074.0K |
Operating Expense | 8,869.0K |
Operating I/L | -9,943.0K |
Other Income/Expense | 2,586.0K |
Interest Income | 0.0K |
Pretax | -7,357.0K |
Income Tax Expense | 8.0K |
Net Income/Loss | -7,365.0K |
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company specializing in diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. The company's Alpha-DaRT technology is utilized in clinical trials for skin, oral, pancreatic, and breast cancers, as well as in preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.